- Report
- January 2026
- 180 Pages
Global
From €4079EUR$4,500USD£3,475GBP
- Report
- January 2026
- 182 Pages
Global
From €4079EUR$4,500USD£3,475GBP
- Report
- January 2026
- 180 Pages
Global
From €4079EUR$4,500USD£3,475GBP
- Report
- January 2026
- 182 Pages
Global
From €4079EUR$4,500USD£3,475GBP
- Report
- January 2026
- 182 Pages
Global
From €4079EUR$4,500USD£3,475GBP
- Report
- January 2026
- 186 Pages
Global
From €4079EUR$4,500USD£3,475GBP
- Report
- January 2026
- 185 Pages
Global
From €4079EUR$4,500USD£3,475GBP
- Report
- July 2025
- 188 Pages
Global
From €4079EUR$4,500USD£3,475GBP
- Report
- May 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- May 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- May 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP

The Third Generation Sequencing market within the Biotechnology industry is a rapidly growing sector. It is a technology that enables the sequencing of entire genomes in a single run, allowing for the analysis of complex genomes and the identification of genetic variants. This technology has enabled researchers to gain a better understanding of the genetic basis of diseases, as well as to develop new treatments and diagnostics. It has also enabled the development of personalized medicine, allowing for the development of treatments tailored to an individual's genetic makeup.
The Third Generation Sequencing market is driven by the increasing demand for personalized medicine, as well as the need for more accurate and efficient sequencing technologies. This has led to increased investment in the sector, with many companies developing new technologies and products. Some of the major players in the market include Illumina, Pacific Biosciences, Oxford Nanopore Technologies, 10X Genomics, and BGI. Show Less Read more